AdaptHealth Corp. Common Stock (AHCO) Stock
Key stats
- Market cap
- $1.06B
- Price / Earnings ratio
- -2.6x
- EPS (TTM)
- -$2.98
- Volume
- Loading
- 52-week high
- $13.43
- 52-week low
- $5.21
Source: third-party data provider, as of November 13, 2026
Compare with AHCO
Recent news

What AdaptHealth (AHCO) Said on Its Q3 Earnings Call
What AdaptHealth (AHCO) Said on Its Q3 Earnings Call
AHCO

AdaptHealth Corp. Announces Third Quarter 2026 Results
AdaptHealth Corp. Announces Third Quarter 2026 Results
AHCO

AdaptHealth Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call
AdaptHealth Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call
AHCO

AdaptHealth To Participate in Upcoming Investor Conferences
AdaptHealth To Participate in Upcoming Investor Conferences
AHCO
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 76.41
- MACD 12/26/9
- 0.41
- EMA 9 of MACD
- 0.23
- MACD histogram
- 0.19
- SMA 50
- $6.12
- Price above SMA 50
- EMA 50
- $6.54
- Price above EMA 50
- SMA 200
- $9.06
- Price below SMA 200
- EMA 200
- $8.49
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

What AdaptHealth (AHCO) Said on Its Q3 Earnings Call
What AdaptHealth (AHCO) Said on Its Q3 Earnings Call
AHCO

AdaptHealth Corp. Announces Third Quarter 2026 Results
AdaptHealth Corp. Announces Third Quarter 2026 Results
AHCO

AdaptHealth Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call
AdaptHealth Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call
AHCO

AdaptHealth To Participate in Upcoming Investor Conferences
AdaptHealth To Participate in Upcoming Investor Conferences
AHCO

AdaptHealth Appoints Harriss Currie as Chief Financial Officer
AdaptHealth Appoints Harriss Currie as Chief Financial Officer
AHCO

AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth
AHCO

Why AdaptHealth Stock Plummeted This Week
Why AdaptHealth Stock Plummeted This Week
AHCO

AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law
AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law
AHCO

AdaptHealth Corp. to Participate in Upcoming Investor Conferences
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
AHCO

AHCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AdaptHealth Corp. (AHCO)
AHCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AdaptHealth Corp. (AHCO)
AHCO
News tone: automated (AI) classification of the article's content, not a price prediction.
About AdaptHealth Corp. Common Stock
AdaptHealth is a home medical equipment and services provider supplying products such as CPAP devices, oxygen equipment, and diabetes management supplies. It works with prescribers and payers, with revenue influenced by reimbursement, patient adherence, and service scale.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Suzanne M. Foster M.P.H. | CEO & Director | 1970 |
| Mr. Jason A. Clemens C.F.A. | Chief Financial Officer | 1979 |
| Mr. Albert A. Prast | CTO & Chief Innovation Officer | 1960 |
| Mr. Russell E. Schuster III | Chief Commercial Officer | 1977 |
| Mr. Daniel McFadden | Chief Operations Officer | 1971 |
| Ms. Christine E. Archbold | Chief Accounting Officer | 1974 |
| Mr. Nalin Narayanam | Chief Information Officer | — |
| Ms. Wendy Russalesi | Chief Compliance Officer | — |
| Mr. Richard W. Rew II | Chief Legal Officer, General Counsel & Secretary | 1968 |
| Ms. Kelly Morgan | Chief Human Resources Officer | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 76.41
- MACD 12/26/9
- 0.41
- EMA 9 of MACD
- 0.23
- MACD histogram
- 0.19
- SMA 50
- $6.12
- Price above SMA 50
- EMA 50
- $6.54
- Price above EMA 50
- SMA 200
- $9.06
- Price below SMA 200
- EMA 200
- $8.49
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $8.00
- Average
- $8.67
- High
- $9.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -22.4 | +32.4 | ||||||||||
| 2022 | -21.1 | -3.0 | +0.7 | -24.0 | +39.9 | +2.2 | +21.7 | -19.4 | +5.9 | +17.4 | -2.8 | -15.0 |
| 2023 | +10.8 | -25.2 | -17.8 | -5.1 | -10.8 | +15.2 | +14.7 | -13.3 | -22.8 | -18.3 | +18.4 | -17.4 |
| 2024 | -0.6 | +39.8 | +9.4 | -12.1 | -5.8 | +4.5 | +16.8 | -1.1 | +3.2 | -6.5 | -4.5 | -5.2 |
| 2025 | +11.5 | +11.1 | -1.5 | -21.3 | +5.6 | +7.8 | -4.6 | +8.5 | -2.2 | -1.3 | +6.3 | +2.2 |
| 2026 | +3.9 | -9.4 | +23.4 | +10.5 | -23.1 | +4.9 | +1.9 | -48.4 | +2.4 | +2.3 | +32.0 |



